AiM Medical Robotics, a leading developer of MRI-safe intraoperative robotics for neurosurgery, will host a panel discussion and present at BioFuture. Registered in-person attendees to BioFuture can view AiM Medical Robotics’ presentation live at the actual event.
Samantha Surrey, Founder of Surrey Capital, will be moderating a panel discussion titled “Neuroinnovation and AI Driven Robotics & Devices: Changing Healthcare” on October 5th at 2:30 pm EST. The panel will consist of:
- Dr. Babak Kateb, Medical Advisory Board at AiM, founding Chairman of the Board of Directors & CEO of SBMT, President and Scientific Director of the Brain Mapping Foundation, Director of National Center for Nano-Bio-Electronics, and Director of Brain Technology and Innovation Park
- Jonathan Sackier, MD, Board of Directors, AiM Medical Robotics
- Greg Simon, Consultant, Simonovation, LLC, Former Executive Director for both the Biden Cancer Initiative and the White House Cancer Moonshot Task Force
Bob Cathcart, President & CEO, will be presenting AiM Medical Robotics at BioFuture on Wednesday, October 6th at 10:45am EST.
“It is an honor to have the opportunity to be a part of this conference and to share how our company looks to shape and transform the way that we think about surgery” said Bob Cathcart. “BioFuture brings together top-notch pioneers, innovators and entrepreneurs to assess the present and shape the future of healthcare, and we certainly believe that our MRI-compatible robotic system will impact the future of healthcare for the better.
“We are delighted that AiM Medical Robotics will be presenting at BioFuture,” said Sara Demy, CEO of Demy-Colton. “BioFuture brings together today’s top innovators, investors and business leaders to discuss the forces shaping the future of healthcare, and identify the potential of innovative, game-changing technologies that will drive the future of drug discovery. We are excited to have AiM participating in this important event.”
Source: AiM Medical Robotics.